PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
152 hedge funds and large institutions have $426M invested in Progenics Pharmaceuticals Inc in 2017 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 66 increasing their positions, 43 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
30% less capital invested
Capital invested by funds: $612M → $426M (-$186M)
Holders
152
Holding in Top 10
–
Calls
$1.67M
Puts
$2.03M
Top Buyers
| 1 | +$9.18M | |
| 2 | +$7.54M | |
| 3 | +$2.88M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.04M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$1.81M |
Top Sellers
| 1 | -$10.8M | |
| 2 | -$9.37M | |
| 3 | -$6.78M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$4.93M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$4.3M |